{"applicableToSamples":"ALL","active":true,"applicableBlocks":["GLIOMA_PATHOGENIC","SNV_PINNED","ONCO_RECOMMENDATIONS","GLIOMA_ASSOCIATED","SECTION","CNV_QUERY","FORMATTED_TEXT","CLINICAL_TRIALS","SAMPLE_INFO","SNV_ACMG_SF","DISCLAIMER","CLINVAR_PHENOTYPES","ONCO_RELEVANT_SNV_MANUAL","PATIENT_INFO","SNV_MANUAL","SIGN_PLACE","NON_GLIOMA_PATHOGENIC","SNV_QUERY"],"blocks":[{"id":"d5f00c73-c027-4977-baaa-5bbccdb53641","reportTemplateId":"0a7cbff3-1372-4812-b91b-321b8e7257d0","type":"SNV_ACMG_SF","ordering":0,"parameters":{"name":"ACMG вторичные находки","description":"Варианты в генах из списка Американского колледжа медицинской генетики и геномики (ACMG), о которых ACMG рекомендует сообщать.","origin":"GERMLINE","maxGnomadFreq":0.03,"interpretationMode":"BY_VARIANTS","transferVariantInterpretationToGeneral":false,"interpretation":"При сообщении о патогенных и вероятно патогенных вариантах следует руководствоваться рекомендациями ACMG по вторичным находкам.","useFirstTierResultsAsPotentialFindings":false,"useSecondTierResultsAsPotentialFindings":false}}],"createdAt":"2026-02-02T18:00:49.838Z","updatedAt":"2026-02-02T18:01:45.835Z","id":"0a7cbff3-1372-4812-b91b-321b8e7257d0","ownerId":"88edbf10-b671-4c15-b1df-4fe81158696c","shortName":"ACMG SF","fullName":null,"description":null}